Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 04/26/16 → 01/5/18 |
Funding
- Ipsen Biopharmaceuticals Incorporated: $6,625.00
A Phase 3, Prospective, Randomized, Double-Blind, Multi-Center, Study of the Efficacy and Safety of Lanreotide Autogel/Depot 120mg Plus BSC vs. Placebo Plus BSC for Tumor Control in Subjects with Well Differentiated, Metastatic and/or ....
- Keresztes, Roger (PI)
- Zhang, Yue (CoPI)
Project: Research